ArticleEndocrine2026

Combination of hsa-miR-21-3p/ sTNF-RI/ IL12-p40 /CCL25 serves as a promising panel of diagnostic biomarkers for distinguishing malignant from benign nodules in papillary thyroid cancer.

Abdulmelik Aytatli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.